The American Diabetes Association’s Standards of Care for 2023, published in Diabetes Care, highlights recent improvements in clinical and holistic aspects of diabetes management, including new hypertension diagnosis cut-offs and recommendations on sleep health and the role of SGLT2-inhibitors for patients with preserved or reduced heart failure ejection fraction. “This year’s annual report provides necessary guidance that considers the role health inequities play in the development of diabetes, particularly for vulnerable communities and communities of color disproportionately impacted by the disease," ADA Chief Executive Officer Chuck Henderson says.
Full Story: Endocrinology Network (12/12)